9th May 2020
For SARS-COV-2 research teams setting-up translational trial models
DECRO, designed by Etisense, is a digitally-connected, wearable device that can monitor respiratory and cardiac functions in early phase clinical trials.
Etisense is offering DECRO to research teams involved in the study of SARS-COV-2 physiopathology.
- The monitoring device is embedded with plethysmographic sensors and electrodes
- The sensors and electrodes are connected to an emitter which transmits signals in bluetooth to a low footprint acquisition server.
The device can be adapted for use in various early phase clinical trials.
More information can be found at www.decro.fr
The offer is available until the end of the year.
ASK: Research contributors needed for CON-VICE study
University of Luxembourg needs European researchers to get in touch
OFFER: Funding available for COVID-19 research
Fondation Air Liquide are looking to fund European projects
ASK: Supporting the immunocompromised
Partners sought to advance neutralising antibody